1life Healthcare Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of 1life Healthcare Inc (ONEM) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: 1life Healthcare Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 1,046M vs 6,028M combined for its competitors (14.8% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+4.9% annualized vs trailing 12 months), vs accelerating (+4.7%) for its tracked peer group.
- Growth: 1life Healthcare Inc generated 19.1% revenue growth year over year in Q4 2022, vs 40.8% for its competitors combined.
- Profitability: Its -36.9% net margin compares with -29.3% for the peer group.
- Peer revenue share: 1life Healthcare Inc accounted for 14.8% of combined revenue among its tracked peer group, down from 17.0% a year earlier.
- Peer differentiation: Revenue per employee of $0.14M compares with $0.50M for the peer group (0.3x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
ONEM Sales vs. its Competitors, Q4 2022
1life Healthcare Inc reported revenue growth of 19.12 % year on year in Q4 2022, below its competitors' combined revenue growth of 40.77 %.
With a net margin of -36.88 %, 1life Healthcare Inc reported lower profitability than its competitors (-29.33 %).
1life Healthcare Inc generated 14.81 % of the combined sales of its peer group, down from 17.04 % a year earlier.
API endpoints for this dataset
1life Healthcare Inc vs. its Competitors, Q4 2022
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in 1life Healthcare Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across 1life Healthcare Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| 1life Healthcare Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (2) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (6) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across 1life Healthcare Inc's competitor groups requires a Commercial License.
For context: the Healthcare Facilities industry grew revenue 14.7% year over year, combined, vs 19.1% for 1life Healthcare Inc. 1life Healthcare Inc's share of combined industry revenue moved from 0.22% to 0.23%, a gain of 0.01 percentage points.
1life Healthcare Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| 1life Healthcare Inc | No | Yes | Yes | No |
| Competitors combined (5) | ||||
| High-Confidence Competitors (2) | ||||
| Similar Growth & Profitability (8) | 25.00 % (2 of 8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 25.00 % (2 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
ONEM Stock Performance relative to its Competitors
ONEM Stock Performance relative to High-Confidence Competitors
ONEM Stock Performance relative to Similar Growth & Profitability Competitors
Publicly Traded Peers of 1life Healthcare Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 1life Healthcare Inc |
3,245.38 | 1,045.55 |
 Oak Street Health Inc |
9,285.65 | 2,399.10 |
 Cue Health Inc |
4,177.69 | 70.94 |
 Augmedix Inc |
125.46 | 50.91 |
 Cano Health Inc |
12.07 | 2,955.27 |
 Caremax Inc |
2.18 | 551.77 |
| SUBTOTAL | 16,848.43 | 7,073.54 |
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on 1life Healthcare Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
1life Healthcare Inc's Competitors Named by the Company
Competitive relationships identified from 1life Healthcare Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Cue Health Inc | Company report | 85% |
| Neuehealth Inc | Company report | 85% |
| Caremax Inc | Company report | 85% |
| Oak Street Health Inc | Company report | 85% |
| Cano Health Inc | Company report | 85% |
| Augmedix Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for 1life Healthcare Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
1life Healthcare Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| 1life Healthcare Inc | 3,245 | 137,373 | -52,273 |
| Oak Street Health Inc | 9,286 | 299,888 | -57,150 |
| Cue Health Inc | 4,178 | 886,700 | -4,668,300 |
| Augmedix Inc | 125 | 192,856 | -90,333 |
| Cano Health Inc | 12 | 1,094,546 | -561,675 |
| Caremax Inc | 2 | 551,766 | -782,856 |
| PEERS TOTAL | 13,603 | 500,497 | -261,864 |
1life Healthcare Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Cue Health Inc | Non-US 0.85 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
1life Healthcare Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Healthcare Facilities industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (113 companies). See the full Healthcare Facilities industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 57.77 % | 34.23 % (avg) | +23.5 pp |
| Operating Margin | -40.14 % | industry median | -46.2 pp |
| EBITDA Margin | -32.19 % | 3.13 % (avg) | -35.3 pp |
| Capital Intensity (Capex / Revenue) | 7.05 % | 3.79 % (avg) | +3.3 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
1life Healthcare Inc's Valuation vs Competitive Position
Valuation multiples vs the Healthcare Facilities industry average (113 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Healthcare Facilities industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 20.6x | - |
| EV / EBITDA | - | 14.5x | - |
| P/B | 2.1x | 3.1x | -1.0x |
| Return on Equity | -24.86 % | industry aggregate | -15.55 % |
| Return on Invested Capital | -10.71 % | 1.94 % (avg) | -12.65 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
1life Healthcare Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenue Growth | - | 37.63 % | 63.93 % | 67.74 % |
| Operating Margin | - | -18.77 % | -39.06 % | -40.14 % |
| Return on Invested Capital | - | -5.21 % | -8.54 % | -10.71 % |
| P/E | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
1life Healthcare Inc's Strategic Group Map
1life Healthcare Inc is shown in red; its closest peers by combined growth, margin and ROIC are labeled. See Methodology: Strategic Group Map for how this chart is built.
1life Healthcare Inc's trailing-12-month revenue growth of 67.7% and operating margin of -40.1% compares with an average of 48.0% growth and -22.4% margin across its 8 closest peers by combined growth, margin and ROIC -- 1life Healthcare Inc sits above that peer average on growth and below it on margin.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
1life Healthcare Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Barriers to Entry | High (capital intensive) | Capital intensity (capex / revenue) of 7.05 % vs industry average 3.79 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on 1life Healthcare Inc's dedicated Suppliers and Customers pages, not here.
1life Healthcare Inc's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
1life Healthcare Inc falls in the Low attractiveness / Medium strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
1life Healthcare Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Latest-quarter revenue run-rate is accelerating (+4.9% annualized vs trailing 12 months).
Weaknesses
- Operating margin 46.2 points below the industry median.
- Return on equity 15.6 points below the industry aggregate.
Opportunities
- A meaningful share of competitors (60.00 %) show financial-distress signals, a possible opening to gain share.
Threats
- High capital intensity requires continuous reinvestment just to keep pace with the industry.
Methodology: see Methodology: SWOT Analysis.
1life Healthcare Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| 1life Healthcare Inc | 0.88 | 2.38 | 0.19 |
| Oak Street Health Inc | 0.15 | 1.46 | - |
| Cue Health Inc | 2.20 | 3.54 | - |
| Augmedix Inc | 1.38 | 1.86 | 1.56 |
| Cano Health Inc | - | 0.31 | - |
| Caremax Inc | 0.10 | 0.41 | 0.73 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
1life Healthcare Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| 1life Healthcare Inc | Q4 2022 | +19.1 % | - |
| Oak Street Health Inc | Q1 2023 | +46.4 % | - |
| Cue Health Inc | Q4 2023 | -87.2 % | - |
| Augmedix Inc | Q2 2024 | +24.8 % | - |
| Cano Health Inc | Q1 2024 | -21.0 % | - |
| Caremax Inc | Q2 2024 | -11.5 % | - |
| PEERS TOTAL | -2.6 % | - |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
1life Healthcare Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| 1life Healthcare Inc | Q4 2022 | +19.9 % | -4.1 % |
| Oak Street Health Inc | Q1 2023 | -72.8 % | -14.1 % |
| Cue Health Inc | Q4 2023 | -60.6 % | -81.8 % |
| Augmedix Inc | Q2 2024 | +22.5 % | -72.2 % |
| Cano Health Inc | Q1 2024 | - | -84.0 % |
| Caremax Inc | Q2 2024 | +6.0 % | -77.3 % |
1life Healthcare Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| 1life Healthcare Inc | - | - | - |
| Oak Street Health Inc | - | - | - |
| Cue Health Inc | - | - | - |
| Augmedix Inc | - | - | - |
| Cano Health Inc | - | - | - |
| Caremax Inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
1life Healthcare Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| 1life Healthcare Inc | - | 3.10 |
| Oak Street Health Inc | - | 3.87 |
| Cue Health Inc | - | 58.89 |
| Augmedix Inc | - | 2.46 |
| Cano Health Inc | - | 0.00 |
| Caremax Inc | - | 0.00 |
| PEERS AVERAGE | - | 2.38 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.